| MeSH term | MeSH ID | Detail |
|---|---|---|
| Peri-Implantitis | D057873 | 1 associated lipids |
| Adrenocortical Adenoma | D018246 | 1 associated lipids |
| Hyperparathyroidism, Primary | D049950 | 1 associated lipids |
| Breast Neoplasms, Male | D018567 | 1 associated lipids |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | D054438 | 1 associated lipids |
| Hashimoto Disease | D050031 | 1 associated lipids |
| Legg-Calve-Perthes Disease | D007873 | 1 associated lipids |
| Fluorosis, Dental | D009050 | 1 associated lipids |
| Bone Demineralization, Pathologic | D018488 | 1 associated lipids |
| POEMS Syndrome | D016878 | 1 associated lipids |
| Fibroma, Ossifying | D018214 | 1 associated lipids |
| Osteolysis, Essential | D010015 | 1 associated lipids |
| Dentin Dysplasia | D003805 | 1 associated lipids |
| Neoplasms, Squamous Cell | D018307 | 1 associated lipids |
| Osteoporotic Fractures | D058866 | 1 associated lipids |
| Hemangioma, Capillary | D018324 | 1 associated lipids |
| Prediabetic State | D011236 | 1 associated lipids |
| Cleidocranial Dysplasia | D002973 | 1 associated lipids |
| Neoplastic Syndromes, Hereditary | D009386 | 1 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:25744546 | ||||
| pmid:25748834 | ||||
| pmid:25756521 | ||||
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Zheng Y et al. | Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. | 2015 | J. Dent. Res. | pmid:25762594 |
| pmid:25795427 | ||||
| Sutton KM et al. | The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. | 2015 | Dev. Comp. Immunol. | pmid:25796577 |
| pmid:25796629 | ||||
| pmid:25797915 | ||||
| pmid:25808546 | ||||
| pmid:25810067 | ||||
| Folestad A et al. | Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. | 2015 | Acta Orthop | pmid:25811776 |
| pmid:25812671 | ||||
| Hassan SH et al. | Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. | 2015 | Dis. Markers | pmid:25814780 |
| pmid:25818584 | ||||
| pmid:25818585 | ||||
| pmid:25819470 | ||||
| pmid:25825337 | ||||
| pmid:25837159 | ||||
| Åšwierkot J et al. | Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. | 2015 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:25837853 |
| pmid:25845543 | ||||
| Wu C et al. | Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. | 2015 | Genes Dev. | pmid:25846796 |
| pmid:25854266 | ||||
| pmid:25857587 | ||||
| Kim KR et al. | 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. | 2015 | PLoS ONE | pmid:25859665 |
| pmid:25859979 | ||||
| Warren JT et al. | Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. | 2015 | J. Cell. Biochem. | pmid:25864714 |
| pmid:25865548 | ||||
| pmid:25866993 | ||||
| pmid:25868799 | ||||
| pmid:25871826 | ||||
| pmid:25871861 | ||||
| Duan P et al. | Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. | 2015 | BMC Womens Health | pmid:25884698 |
| Shen Y et al. | (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. | 2015 | BMC Complement Altern Med | pmid:25887296 |
| Su F et al. | Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. | 2015 | Stem Cell Res Ther | pmid:25888745 |
| Wei J et al. | Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. | 2015 | Mol Med Rep | pmid:25891179 |
| pmid:25895663 | ||||
| pmid:25912212 | ||||
| pmid:25920618 | ||||
| pmid:25926154 | ||||
| pmid:25926255 | ||||
| pmid:25930677 | ||||
| pmid:25931273 | ||||
| Bortolin RH et al. | Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. | 2015 | PLoS ONE | pmid:25933189 |
| pmid:25934570 | ||||
| Reveille JD | Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. | 2015 | Clin. Rheumatol. | pmid:25939520 |
| pmid:25944420 | ||||
| pmid:25953955 | ||||
| pmid:25956608 | ||||
| Ardeshirpour L et al. | OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. | 2015 | Endocrinology | pmid:25961842 |
| pmid:25962765 | ||||
| pmid:25967665 | ||||
| pmid:25968958 | ||||
| Ehlken C et al. | Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. | 2015 | PLoS ONE | pmid:25978399 |
| Yang Y et al. | The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. | 2015 | J. Biol. Chem. | pmid:25979341 |
| pmid:25982995 | ||||
| Priyadarshi S et al. | Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. | 2015 | Ann. Hum. Genet. | pmid:25998045 |
| Liu G et al. | Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. | 2016 | Cell Tissue Res. | pmid:26004143 |
| Tanaka Y et al. | [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. | 2015 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:26016635 |
| pmid:26016944 | ||||
| Beederman M et al. | Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. | 2015 | Plast. Reconstr. Surg. | pmid:26017615 |
| pmid:26018435 | ||||
| pmid:26025293 | ||||
| Goyden J et al. | The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. | 2015 | PLoS ONE | pmid:26030441 |
| Harrison R et al. | Acute bone response to whole body vibration in healthy pre-pubertal boys. | 2015 | J Musculoskelet Neuronal Interact | pmid:26032203 |
| Davenport C et al. | The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes. | 2015 | Eur. J. Endocrinol. | pmid:26036811 |
| Janda K et al. | Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. | 2015 | BMC Nephrol | pmid:26037625 |
| Kuroyanagi G et al. | Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. | 2015 | Mol Med Rep | pmid:26044505 |
| pmid:26044709 | ||||
| pmid:26044839 | ||||
| Kastritis E et al. | Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. | 2015 | Blood Cancer J | pmid:26047389 |
| Weichhaus M et al. | Osteoprotegerin in breast cancer: beyond bone remodeling. | 2015 | Mol. Cancer | pmid:26054853 |
| pmid:26057821 | ||||
| Rzepka R et al. | Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. | 2015 | BMC Pregnancy Childbirth | pmid:26059227 |
| pmid:26062841 | ||||
| Davenport C et al. | The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes. | 2015 | J Diabetes Res | pmid:26064990 |
| Zavala-Cerna MG et al. | Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. | 2015 | J Immunol Res | pmid:26065000 |
| Collins FL et al. | Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. | 2015 | J Immunol Res | pmid:26065008 |
| pmid:26069065 | ||||
| Burton LJ et al. | Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. | 2015 | Carcinogenesis | pmid:26069256 |
| Pietschmann P et al. | Immunology of Osteoporosis: A Mini-Review. | 2016 | Gerontology | pmid:26088283 |
| Ketlogetswe KS et al. | Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. | 2015 | J. Acquir. Immune Defic. Syndr. | pmid:26090754 |
| pmid:26092508 | ||||
| pmid:26093292 | ||||
| Telejko B et al. | The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. | 2015 | Ann Agric Environ Med | pmid:26094529 |
| Kondegowda NG et al. | Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. | 2015 | Cell Metab. | pmid:26094891 |
| Schmitz F et al. | Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. | 2015 | Cell Metab. | pmid:26094892 |
| pmid:26096594 | ||||
| Yu SG et al. | Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. | 2015 | Int J Clin Exp Pathol | pmid:26097549 |
| pmid:26099662 | ||||
| pmid:26112994 | ||||
| pmid:26117426 | ||||
| pmid:26118194 | ||||
| Ye XH et al. | Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. | 2015 | Genet. Mol. Res. | pmid:26125863 |
| pmid:26131575 | ||||
| pmid:26133738 | ||||
| pmid:26143141 | ||||
| Bartosińska J et al. | The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. | 2015 | Mediators Inflamm. | pmid:26146462 |
| Miao X et al. | Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. | 2015 | J Orthop Surg Res | pmid:26148858 |
| pmid:26149648 |